DE69719098D1 - Verfahren zur herstellung von citalopram - Google Patents

Verfahren zur herstellung von citalopram

Info

Publication number
DE69719098D1
DE69719098D1 DE69719098T DE69719098T DE69719098D1 DE 69719098 D1 DE69719098 D1 DE 69719098D1 DE 69719098 T DE69719098 T DE 69719098T DE 69719098 T DE69719098 T DE 69719098T DE 69719098 D1 DE69719098 D1 DE 69719098D1
Authority
DE
Germany
Prior art keywords
producing citalopram
citalopram
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69719098T
Other languages
English (en)
Other versions
DE69719098T2 (de
Inventor
Hans Petersen
Peter Bogeso
Sommer Michael Bech
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37709809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69719098(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Application granted granted Critical
Publication of DE69719098D1 publication Critical patent/DE69719098D1/de
Publication of DE69719098T2 publication Critical patent/DE69719098T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69719098T 1997-11-10 1997-11-10 Verfahren zur herstellung von citalopram Revoked DE69719098T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB971825017A CN100338051C (zh) 1997-11-10 1997-11-10 西酞普兰的制备方法
PCT/DK1997/000511 WO1998019511A2 (en) 1997-11-10 1997-11-10 Method for the preparation of citalopram

Publications (2)

Publication Number Publication Date
DE69719098D1 true DE69719098D1 (de) 2003-03-20
DE69719098T2 DE69719098T2 (de) 2004-02-12

Family

ID=37709809

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69719098T Revoked DE69719098T2 (de) 1997-11-10 1997-11-10 Verfahren zur herstellung von citalopram
DE1032566T Pending DE1032566T1 (de) 1997-11-10 1997-11-10 Verfahren zur herstellung von citalopram

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1032566T Pending DE1032566T1 (de) 1997-11-10 1997-11-10 Verfahren zur herstellung von citalopram

Country Status (21)

Country Link
US (1) US6291689B1 (de)
EP (1) EP1032566B9 (de)
JP (1) JP2002530296A (de)
CN (1) CN100338051C (de)
AR (1) AR029604A2 (de)
AT (1) ATE232524T1 (de)
AU (1) AU738526C (de)
BR (1) BR9714924A (de)
CA (1) CA2291068C (de)
CZ (1) CZ296533B6 (de)
DE (2) DE69719098T2 (de)
DK (1) DK1032566T5 (de)
EA (1) EA003132B1 (de)
ES (1) ES2149141T4 (de)
IL (1) IL135813A (de)
IS (1) IS5473A (de)
SK (1) SK6812000A3 (de)
TR (1) TR200001314T2 (de)
UA (1) UA62985C2 (de)
WO (1) WO1998019511A2 (de)
ZA (1) ZA9810059B (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CA2291072C (en) 1997-11-11 2002-08-20 H. Lundbeck A/S Method for the preparation of citalopram
DK1123284T3 (da) 1998-10-20 2003-04-28 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
SI1140886T1 (en) 1998-12-23 2003-08-31 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) * 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
HU227473B1 (en) 1999-04-14 2011-07-28 Lundbeck & Co As H Method for preparation of citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ATE277032T1 (de) * 1999-10-25 2004-10-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
SK287139B6 (sk) * 1999-10-25 2010-01-07 H. Lundbeck A/S Spôsob prípravy citalopramu
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
AU778751B2 (en) 1999-12-28 2004-12-16 H. Lundbeck A/S Method for the preparation of citalopram
EP1246813B1 (de) * 1999-12-30 2003-11-05 H. Lundbeck A/S Verfahren zur herstellung von citalopram
EA005134B1 (ru) 2000-01-14 2004-12-30 Х.Лундбекк А/С Способ получения 5-цианофталида
US6433196B1 (en) 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
NL1017415C1 (nl) * 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
IES20010206A2 (en) * 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
GR1004072B (el) * 2000-03-13 2002-12-02 H.Lundbeck A/S Μεθοδος παρασκευης της σιταλοπραμης
EA200200969A1 (ru) * 2000-03-13 2003-02-27 Х.Лундбекк А/С Способ получения циталопрама
TR200202195T2 (tr) 2000-03-13 2002-12-23 H. Lundbeck A/S 5-Yer değiştirmiş 1-(4-florofenil)-1,3- dihidroizobenzofuran'ın adım adım alkillenmesi
ES2214400T3 (es) 2000-03-14 2004-09-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
JP2003527388A (ja) * 2000-03-16 2003-09-16 ハー・ルンドベック・アクチエゼルスカベット ５−シアノ−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフランの製造方法
AR032455A1 (es) * 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CA2354877C (en) * 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
US6491947B2 (en) 2000-11-03 2002-12-10 Chemlink Laboratories, Llc Expanded perborate salt, use, and method of production
IT1319686B1 (it) * 2000-12-12 2003-10-23 C D Farmasint S R L Procedimento di preparazione di citalopram.
SI1181713T1 (en) 2000-12-22 2005-02-28 H. Lundbeck A/S Method for the preparation of pure citalopram
CA2359810C (en) * 2000-12-28 2002-11-05 H. Lundbeck A/S Process for the preparation of pure citalopram
EP1355897A1 (de) 2001-01-30 2003-10-29 Orion Corporation Fermion Verfahren zur herstellung von 1-(3-dimethylaminopropyl)-1-(4-fluorphenyl)-1,3-dihydrobenzofuran-5-carbonitrile
BG65271B1 (bg) * 2001-06-18 2007-11-30 H. Lundbeck A/S Метод за получаване на циталопрам
MEP2108A (xx) 2001-07-31 2010-02-10 Lundbeck & Co As H Kristalni sastav koji sadrži escitalopram
KR100903841B1 (ko) * 2002-03-27 2009-06-25 반도 카가쿠 가부시키가이샤 신규의 1,3,5-트리스(아릴아미노)벤젠류
BG65515B1 (bg) * 2002-07-26 2008-10-31 H. Lundbeck A/S Метод за получаване на 5-цианофталид
FI20021421A0 (fi) * 2002-07-30 2002-07-30 Orion Corp Fermion Valmistusmenetelmä
TWI306846B (en) * 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
AU2002330730A1 (en) * 2002-08-14 2004-03-03 Natco Pharma Limited Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts
GB2385051B (en) * 2002-08-29 2003-12-24 Max India Ltd Improved process for the preparation of 5-substituted-1 (4-fluorophenyl)-1,3-dihydro isobenzofurans
WO2004026855A1 (en) * 2002-09-20 2004-04-01 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
ITMI20030479A1 (it) * 2003-03-13 2004-09-14 Adorkem Technology S P A Procedimento per la preparazione di un ciano-isobenzofurano.
WO2004083197A2 (en) 2003-03-21 2004-09-30 H. Lundbeck A/S Intermediates for the preparation of citalopram and escitalopram
AU2003238676A1 (en) * 2003-04-21 2004-11-19 Podile Khadgapathi An improved process for the preparation of citalopram hydrobromide
US6781003B1 (en) * 2003-06-09 2004-08-24 Aurobindo Pharma Ltd. Preparation of pure citalopram
ATE293106T1 (de) * 2003-10-28 2005-04-15 Adorkem Technology Spa Verfahren zur herstellung von citalopram
CN100569765C (zh) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
CA2559703A1 (en) * 2004-02-16 2005-08-25 Jubilant Organosys Limited One pot synthesis of citalopram from 5-cyanophthalide
ES2285972T1 (es) 2004-08-23 2007-12-01 Sun Pharmaceutical Industries Limited Procedimiento de fabricacion de citalopram y enantiomeros.
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (de) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
EP0721941A4 (de) * 1994-07-15 1996-09-25 Meiji Seika Co Neue verbindungen mit aggregations-hemmenden wirkung auf bluttplättchen
JP3526581B2 (ja) 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CA2291072C (en) 1997-11-11 2002-08-20 H. Lundbeck A/S Method for the preparation of citalopram

Also Published As

Publication number Publication date
CZ296533B6 (cs) 2006-04-12
CA2291068A1 (en) 1998-05-14
ES2149141T4 (es) 2004-11-16
CZ20001713A3 (cs) 2000-10-11
BR9714924A (pt) 2000-09-26
JP2002530296A (ja) 2002-09-17
WO1998019511A2 (en) 1998-05-14
EA200000509A1 (ru) 2000-10-30
SK6812000A3 (en) 2000-10-09
UA62985C2 (en) 2004-01-15
IL135813A (en) 2003-07-31
EA003132B1 (ru) 2003-02-27
WO1998019511A3 (en) 1998-08-06
DE69719098T2 (de) 2004-02-12
AU5116798A (en) 1998-05-29
ES2149141T3 (es) 2003-10-01
IL135813A0 (en) 2001-05-20
CA2291068C (en) 2002-10-29
CN100338051C (zh) 2007-09-19
AU738526C (en) 2004-03-25
CN1286688A (zh) 2001-03-07
EP1032566B9 (de) 2003-10-22
AU738526B2 (en) 2001-09-20
ES2149141T1 (es) 2000-11-01
DK1032566T3 (da) 2003-06-10
EP1032566A2 (de) 2000-09-06
US6291689B1 (en) 2001-09-18
DE1032566T1 (de) 2001-03-15
IS5473A (is) 2000-04-26
TR200001314T2 (tr) 2000-11-21
ATE232524T1 (de) 2003-02-15
ZA9810059B (en) 1999-05-05
AR029604A2 (es) 2003-07-10
EP1032566B1 (de) 2003-02-12
DK1032566T5 (da) 2004-06-28

Similar Documents

Publication Publication Date Title
DE69719098D1 (de) Verfahren zur herstellung von citalopram
ATE230738T1 (de) Verfahren zur herstellung von citalopram
DE59708146D1 (de) Verfahren zur herstellung von polyalkoholen
DE69618020T2 (de) Verfahren zur herstellung von hydrofluorethern
ATE194850T1 (de) Verfahren zur herstellung von peroxiperfluoropolyxyalkylene
DE59705109D1 (de) Verfahren zur herstellung von arylcyanaten
DE59702087D1 (de) Verfahren zur herstellung von phthaliden
ATE198318T1 (de) Verfahren zur herstellung von n-acetonylbenzamide
DE59704683D1 (de) Verfahren zur herstellung von 6-aminocapronitril
DE69819191D1 (de) Verfahren zur herstellung von pentafluorethan
DE59805920D1 (de) Verfahren zur herstellung von oxazaphosphorin-2-aminen
ATE221056T1 (de) Verfahren zur herstellung von benzisothiazolin-3- onen
DE69733152D1 (de) Verfahren zur herstellung von tetrazolylbenzopyranen
DE59704682D1 (de) Verfahren zur herstellung von 6-aminocapronitril
DE69806759D1 (de) Verfahren zur herstellung von pentafluorethan
DE69708137T2 (de) Verfahren zur herstellung von difluormethan
ATE237607T1 (de) Verfahren zur herstellung von 3-ispchromanon
DE69802546D1 (de) Verfahren zur herstellung von tuftingware
DE59811807D1 (de) Verfahren zur herstellung von chlorbenzoxazolen
DE59802548D1 (de) Verfahren zur herstellung von webware
DE59805432D1 (de) Verfahren zur herstellung von 2-cyclododecyl-1-propanol
DE59803768D1 (de) Verfahren zur herstellung von phthaliden
DE69808100T2 (de) Verfahren zur herstellung von 3-isochromanon
ATE376544T1 (de) Verfahren zur herstellung von formylimidazolen
DE59807347D1 (de) Verfahren zur herstellung von fluorkohlenwasserstoffen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation